Uranus Chemicals Co., LTD. (TPEX:7742)
Taiwan · Delayed Price · Currency is TWD 182.50
+11.50 (6.73%)
At close: May 8, 2026
TPEX:7742 Revenue
In the year 2025, Uranus Chemicals Co., LTD. had annual revenue of 1.17B TWD with 42.43% growth. Uranus Chemicals Co., LTD. had revenue of 871.68M in the half year ending December 31, 2025, with 122.56% growth.
Revenue
1.17B
Revenue Growth
+42.43%
P/S Ratio
10.35
Revenue / Employee
10.84M
Employees
108
Market Cap
12.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.17B | 348.74M | 42.43% |
| Dec 31, 2024 | 821.91M | 95.62M | 13.17% |
| Dec 31, 2023 | 726.29M | -591.46M | -44.88% |
| Dec 31, 2022 | 1.32B | 323.82M | 32.58% |
| Dec 31, 2021 | 993.92M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dimerco Express | 29.68B |
| Great Tree Pharmacy | 18.90B |
| Egis Technology | 5.33B |
| Universal Vision Biotechnology | 4.20B |
| Taiwan Chinsan Electronic Industrial | 3.77B |
| Alcor Micro,Corp. | 2.88B |
| Eris Technology | 2.70B |
| Handa Pharmaceuticals | 1.73B |